Cyproheptadine HydrochlorideThird Party Manufacturing in India

Cyproheptadine hydrochloride is a first-generation antihistamine that exerts its pharmacological effects through potent antagonism of multiple neurotransmitter receptors. The drug acts primarily as a competitive inverse agonist at histamine H1 receptors, blocking the action of histamine released from mast cells and basophils during allergic reactions. This H1 receptor blockade prevents histamine-mediated vasodilation, increased capillary permeability, bronchoconstriction, and sensory nerve stimulation, thereby alleviating symptoms such as itching, sneezing, rhinorrhoea, and urticaria. Unlike second-generation antihistamines, cyproheptadine readily crosses the blood-brain barrier, producing central H1 receptor blockade that contributes to its sedative properties. The drug also exhibits significant antiserotonergic activity through antagonism of 5-HT2A and 5-HT2C serotonin receptors. The 5-HT2C blockade in the hypothalamus is believed to be the primary mechanism underlying the drug's well-documented appetite-stimulating effect, as serotonin normally exerts an inhibitory tone on food intake through these receptors. Additionally, cyproheptadine possesses anticholinergic activity through muscarinic receptor blockade, antikinin activity, and weak local anaesthetic properties. This broad receptor profile makes cyproheptadine useful in conditions beyond simple allergy, including migraine prophylaxis, serotonin syndrome management, and appetite stimulation in underweight patients and children with failure to thrive.

Therapeutic Uses

Cyproheptadine Hydrochloride is a versatile first-generation antihistamine with a broad range of clinical applications extending beyond simple allergic conditions.

• Allergic Rhinitis and Conjunctivitis: Provides symptomatic relief from seasonal and perennial allergic rhinitis, including sneezing, rhinorrhoea, itchy nose, and itchy watery eyes.
• Urticaria and Angioedema: First-line treatment for acute and chronic urticaria, including physical urticarias, due to its potent H1 receptor blockade.
• Appetite Stimulation: Widely prescribed for appetite stimulation in underweight children, patients with anorexia, and those with failure to thrive. Its 5-HT2C antagonism increases appetite and food intake.
• Migraine Prophylaxis: Used off-label for migraine prevention in both adults and children, particularly when other prophylactic agents have failed.
• Serotonin Syndrome: A valuable treatment option for serotonin syndrome due to its potent 5-HT2A receptor antagonism.
• Carcinoid Syndrome: Helps control diarrhoea and flushing in patients with carcinoid tumours.

Why Manufacturers Choose Cyproheptadine Hydrochloride

Cyproheptadine is one of the most widely prescribed first-generation antihistamines in India, driven by its dual utility as an antiallergic and appetite stimulant. Pediatricians represent a particularly strong prescriber base, prescribing cyproheptadine for appetite stimulation in children — a use for which it has few competitors. The manufacturing process is mature and cost-effective, with readily available API from multiple domestic and Chinese suppliers. The tablet formulation at 4mg strength is straightforward to produce, making it an ideal entry point for contract manufacturers serving the PCD franchise market. The drug is included in many WHO essential medicines lists and enjoys steady demand from institutional buyers, government tenders, and export markets across Africa, Southeast Asia, and Latin America.